DURHAM, N.C.--(BUSINESS WIRE)--PharPoint Research today announced the addition of Jennifer Bruce as the new Director of Clinical Operations department.
"Jenny's breadth of experience in clinical services and her commitment to quality and client delight make her the perfect addition to our senior management team" said Audra McRae, PharPoint Research's Chief Operating Officer. "Her solid skill set and hands on approach will be instrumental for growth and global expansion of our clinical service offering at PharPoint Research."
In addition, Steve Young has been tapped to fill the new role as Director of Integrated Clinical Strategies.
With the success of the organization, there is a need to establish and cultivate strategic partnerships to allow the company to expand our service offerings and geographic reach around the world." said Art Holmes, company President and CEO. "We are very excited that Steve is willing to step into this role. His industry acumen is invaluable to allow the company to strategically align with partners to offer services globally."
About PharPoint Research
PharPoint Research, Inc. is a pharmaceutical and companion animal industry development service provider specializing in full service delivery to include project management, clinical monitoring, data management, biostatistics and medical writing. Our highly experienced staff includes some of the most talented professionals in the industry.
PharPoint Research understands the importance of responsiveness and timely deliverables with exceptional quality. We pride ourselves on maintaining an excellent repeat client rate and the ability to deliver custom solutions to our clients' clinical trial needs. Founded in 2005, PharPoint Research is headquartered in NC. For more information, visit www.pharpoint.com.
